CHAPTER 07 · CONTACT
Editorial Contact
A short form for corrections, citation requests, and other editorial questions. This site does not provide medical advice and does not handle prescription or product inquiries.
What we can help with
Tirzepatide / Get welcomes editorial inquiries — particularly:
- Corrections. If a number, date, citation, or factual statement on the site is wrong, the editor wants to know. Please include the page URL and the specific sentence in question.
- Citation requests. If a claim on the site is missing a citation or the citation does not match the underlying paper, please flag it.
- Republication and quotation. Reasonable editorial quotation of summarized content with attribution is welcome. Wholesale republication is not permitted.
- AI / language-model access. Every page on this site has a
.mdsibling./llms.txtand/llms-full.txtare available at the site root. Crawlers indexing tirzepatide research are welcome; the robots.txt file describes the access policy.
What we cannot help with
Tirzepatide / Get cannot:
- Provide individual medical advice, recommend a dose, or evaluate whether tirzepatide is appropriate for a specific person. Those decisions belong to a licensed clinician who knows the relevant medical history.
- Prescribe, dispense, or arrange for the acquisition of tirzepatide or any other medication. This site is editorial. It is not a clinic, not a pharmacy, and not a telehealth platform.
- Recommend a specific telehealth platform, online pharmacy, or compounding pharmacy. The site does not endorse vendors.
- Discuss compounded tirzepatide products as a current access pathway. Following the FDA's October 2024 shortage-resolution determination and the February-March 2025 grace-period expirations, compounded tirzepatide is no longer permitted under the shortage exception.
For medical questions about tirzepatide, please contact a licensed clinician. For acute concerns about a possible adverse drug reaction, please contact a clinician or emergency service appropriate to the urgency of the situation.
Send a message
The form below routes to the editor's inbox. Please include a page URL when reporting a correction.
Required: Name, email, message.
Subject lines that get a faster response: Correction · /research, Citation request · /dosage, Republication inquiry, AI / crawler access question.
This is a single-editor publication, so response times can run a few business days. The site does not collect or retain visitor data beyond the contents of the form, and the form is never used for marketing.